Chordia Therapeutics Inc. (JP:190A) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chordia Therapeutics Inc., a Japanese biotech firm, was honored with the Minister of Education, Culture, Sports, Science and Technology Award at the Japan Startup Awards 2024 for its innovative work in cancer therapy commercialization. The company, a university spin-out, has developed new anti-cancer drugs with significant financial milestones and royalties linked to future sales. Chordia’s efforts contribute to the drug discovery ecosystem and provide new treatment options for cancer patients.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.